Profile | GDS2987 / GI_34222182-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 7.8 | 26 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 11.2 | 26 |
GSM215344 | HMVEC_atorvastatin_rep2 | 0.3 | 1 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 121.3 | 76 |
GSM215298 | PASMC_vehicle_rep2 | 129.6 | 76 |
GSM215310 | PASMC_vehicle_rep3 | 145.4 | 78 |
GSM215311 | PASMC_atorvastatin_rep1 | 89.5 | 73 |
GSM215312 | PASMC_atorvastatin_rep2 | 138.6 | 77 |
GSM215313 | PASMC_atorvastatin_rep3 | 60.4 | 64 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 213 | 81 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 187.9 | 80 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 162.6 | 79 |
GSM215327 | PASMC_SLx2119_rep1 | 116.6 | 76 |
GSM215328 | PASMC_SLx2119_rep2 | 111.6 | 76 |
GSM215329 | PASMC_SLx2119_rep3 | 119.8 | 76 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 24.6 | 54 |
GSM215332 | Fibroblasts_vehicle_rep3 | 34.8 | 65 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 10.7 | 28 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 21.3 | 50 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 26.2 | 53 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 0.9 | 3 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 26.9 | 60 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 25 | 55 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 27.4 | 59 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 35 | 63 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 40.2 | 64 |